Dc638251 B0c4 46b0 B3b4 07c10c50e94a 00
Duloxetine Hydrochloride
Product Images NDC 63187-457
10 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Duloxetine Hydrochloride (NDC 63187-457). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Structure (Duloxetinedrcapsules Figure 01)
Chemical structure of duloxetine hydrochloride showing a bicyclic ring system with attached methylamine and thiophene groups, consistent with the active ingredient duloxetine hydrochloride.*
1 (Duloxetinedrcapsules Figure 02)
A line graph showing the percentage of patients achieving various levels of pain relief measured by 24-hour average pain severity in a study labeled DPNP-1. The x-axis represents percent improvement in pain from baseline, while the y-axis shows the percentage of patients improved. The graph compares four groups: Duloxetine 60 mg BID, Duloxetine 60 mg QD, Duloxetine 20 mg QD, and placebo, illustrating their relative effectiveness in pain relief.*
2 (Duloxetinedrcapsules Figure 03)
A line graph titled 'Percentage of Patients Achieving Various Levels of Pain Relief as Measured by 24-Hour Average Pain Severity – DPNP-2'. It displays the percentage of patients improved on the y-axis against percent improvement in pain from baseline on the x-axis. Three lines are shown: Duloxetine 60 mg BID, Duloxetine 60 mg QD, and Placebo, illustrating comparative pain relief outcomes over increasing pain improvement percentages.*
Graph (Duloxetinedrcapsules Figure 04)
A line graph comparing the percentage of patients achieving various levels of pain improvement from baseline between placebo and Duloxetine 60/120 mg once daily. The x-axis shows percent improvement in pain from baseline, and the y-axis shows the percentage of patients improved. Duloxetine shows a higher percentage of patient improvement across different pain relief thresholds compared to placebo.*
Figure 6 (Duloxetinedrcapsules Figure 05)
A line graph showing the percentage of patients achieving various levels of pain relief measured by 24-hour average pain severity (CLBP-3). The x-axis represents percent improvement in pain from baseline (BOCF) ranging from 0 to 100, and the y-axis shows the percentage of patients improved from 0 to 100. Two data lines compare Placebo and Duloxetine 60 mg once daily, with Duloxetine consistently showing higher percentages of patient improvement across pain reduction levels.*
Graph (Duloxetinedrcapsules Figure 06)
A line graph showing the percentage of patients achieving various levels of pain relief as measured by 24-hour average pain severity. The x-axis represents percent improvement in pain from baseline (BOCF) in increments from greater than 0 to 100, and the y-axis shows percentage of patients improved from 0 to 100%. Two lines compare placebo and Duloxetine 60/120 mg once daily, with Duloxetine consistently showing higher percentages of patient improvement across the range.*
Logo (Duloxetinedrcapsules Figure 07)
Logo (Duloxetinedrcapsules Figure 08)
Image 01
Label for Duloxetine 60mg delayed-release (DR) capsules by Proficient Rx LP, NDC 63187-457-30. The label states the package contains 30 capsules. Each capsule contains 67.36mg duloxetine hydrochloride, USP equivalent to 60mg duloxetine. Capsules are size '1' hard gelatin with an opaque blue cap and yellow body, imprinted '60 mg' on the body and '1111' on the cap. Manufacturer is Torrent Pharmaceuticals Ltd., India. Storage instructions are 20°-25°C (68°-77°F).*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
